Venturi Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$2.35K 649
2024
Q4
$2.35K Hold
100
﹤0.01% 1829
2024
Q3
$2.56K Hold
100
﹤0.01% 1628
2024
Q2
$2.35K Sell
100
-39
-28% -$984 ﹤0.01% 1345
2024
Q1
$4K Sell
139
-41
-23% -$1.23K ﹤0.01% 1140
2023
Q4
$5.91K Buy
180
+4
+2% +$109 ﹤0.01% 998
2023
Q3
$4.9K Sell
176
-44
-20% -$1.44K ﹤0.01% 989
2023
Q2
$7.5K Buy
220
+44
+25% +$1.38K ﹤0.01% 693
2023
Q1
$5.29K Buy
+176
New +$5.45K ﹤0.01% 814

Other funds holding ARKG

Venturi Wealth Management's ARKG Position: Q1 2025 in Review

Venturi Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 100 shares — an estimated $2.35K sold.

Venturi Wealth Management first reported a position in ARKG in Q1 2023 and held it in 8 quarters. The position peaked at $7.5K in Q2 2023. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Venturi Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 100 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $2.35K.
  • Venturi Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 8 quarters.
  • Venturi Wealth Management's ARK Genomic Revolution ETF position peaked at $7.5K in Q2 2023.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.